110 related articles for article (PubMed ID: 32029438)
1. Propranolol: What is BLOCKing Its Clinical Investigation in Breast Cancer?
Blaes AH; Domingo-Musibay E; Kalinsky K
Clin Cancer Res; 2020 Apr; 26(8):1781-1783. PubMed ID: 32029438
[TBL] [Abstract][Full Text] [Related]
2. Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial.
Hiller JG; Cole SW; Crone EM; Byrne DJ; Shackleford DM; Pang JB; Henderson MA; Nightingale SS; Ho KM; Myles PS; Fox S; Riedel B; Sloan EK
Clin Cancer Res; 2020 Apr; 26(8):1803-1811. PubMed ID: 31754048
[TBL] [Abstract][Full Text] [Related]
3. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
[TBL] [Abstract][Full Text] [Related]
4. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.
Montoya A; Varela-Ramirez A; Dickerson E; Pasquier E; Torabi A; Aguilera R; Nahleh Z; Bryan B
Biomed J; 2019 Jun; 42(3):155-165. PubMed ID: 31466709
[TBL] [Abstract][Full Text] [Related]
5. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.
Zhang LN; Huang YH; Zhao L
Arch Biochem Biophys; 2019 Nov; 676():108137. PubMed ID: 31605677
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
8. In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer.
Alkatout I; Hübner F; Wenners A; Hedderich J; Wiedermann M; Sánchez C; Röcken C; Mathiak M; Maass N; Klapper W
Exp Mol Pathol; 2017 Apr; 102(2):268-275. PubMed ID: 28232080
[TBL] [Abstract][Full Text] [Related]
9. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
10. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
11. The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis.
Li CJ; Chu PY; Yiang GT; Wu MY
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31514467
[TBL] [Abstract][Full Text] [Related]
12. U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.
Caccuri F; Ronca R; Laimbacher AS; Berenzi A; Steimberg N; Campilongo F; Mazzuca P; Giacomini A; Mazzoleni G; Benetti A; Caselli E; Presta M; Di Luca D; Fraefel C; Caruso A
Oncotarget; 2017 Jul; 8(27):44533-44549. PubMed ID: 28562350
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
14. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
[TBL] [Abstract][Full Text] [Related]
15. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.
Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
[No Abstract] [Full Text] [Related]
16. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
17. FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition.
Chu TL; Zhao HM; Li Y; Chen AX; Sun X; Ge J
Biochem Biophys Res Commun; 2014 Apr; 446(2):580-4. PubMed ID: 24632201
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
Zhao M; Ang L; Huang J; Wang J
Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
20. A Novel 3-Dimensional Co-culture Method Reveals a Partial Mesenchymal to Epithelial Transition in Breast Cancer Cells Induced by Adipocytes.
Pallegar NK; Garland CJ; Mahendralingam M; Viloria-Petit AM; Christian SL
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):85-97. PubMed ID: 30474817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
